Journal
JOURNAL OF THE AMERICAN HEART ASSOCIATION
Volume 12, Issue 3, Pages -Publisher
WILEY
DOI: 10.1161/JAHA.122.028121
Keywords
biomechanics; mechanotransduction; pulmonary hypertension due to left heart failure; pulmonary vascular remodeling
Categories
Ask authors/readers for more resources
Combined pre-/postcapillary pulmonary hypertension (Cpc-PH), a complication of left heart failure, leads to higher mortality rates compared to isolated postcapillary pulmonary hypertension alone. However, little is known about the mechanisms responsible for the progression from isolated postcapillary pulmonary hypertension (Ipc-PH) to Cpc-PH. This review focuses on the biomechanical and mechanobiological impact of left heart failure on pulmonary circulation, including the altered biological signaling and detrimental remodeling that drive the progression to Cpc-PH. Understanding these mechanisms may help identify potential pharmacologic approaches to prevent right heart failure and subsequent mortality.
Combined pre-/postcapillary pulmonary hypertension (Cpc-PH), a complication of left heart failure, is associated with higher mortality rates than isolated postcapillary pulmonary hypertension alone. Currently, knowledge gaps persist on the mechanisms responsible for the progression of isolated postcapillary pulmonary hypertension (Ipc-PH) to Cpc-PH. Here, we review the biomechanical and mechanobiological impact of left heart failure on pulmonary circulation, including mechanotransduction of these pathological forces, which lead to altered biological signaling and detrimental remodeling, driving the progression to Cpc-PH. We focus on pathologically increased cyclic stretch and decreased wall shear stress; mechanotransduction by endothelial cells, smooth muscle cells, and pulmonary arterial fibroblasts; and signaling-stimulated remodeling of the pulmonary veins, capillaries, and arteries that propel the transition from Ipc-PH to Cpc-PH. Identifying biomechanical and mechanobiological mechanisms of Cpc-PH progression may highlight potential pharmacologic avenues to prevent right heart failure and subsequent mortality.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available